BACKGROUND: Slowed Na⁺ current (INa) decay and enhanced late INa (INa-L) prolong the action potential duration (APD) and contribute to early afterdepolarizations. Cardiac resynchronization therapy (CRT) shortens APD compared with dyssynchronous heart failure (DHF); however, the role of altered Na⁺ channel gating in CRT remains unexplored. METHODS AND RESULTS: Adult dogs underwent left-bundle branch ablation and right atrial pacing (200 beats/min) for 6 weeks (DHF) or 3 weeks followed by 3 weeks of biventricular pacing at the same rate (CRT). INa and INa-L were measured in left ventricular myocytes from nonfailing, DHF, and CRT dogs. DHF shifted voltage-dependence of INa availability by -3 mV compared with nonfailing, enhanced intermediate inactivation, and slowed recovery from inactivation. CRT reversed the DHF-induced voltage shift of availability, partially reversed enhanced intermediate inactivation but did not affect DHF-induced slowed recovery. DHF markedly increased INa-L compared with nonfailing. CRT dramatically reduced DHF-induced enhanced INa-L, abbreviated the APD, and suppressed early afterdepolarizations. CRT was associated with a global reduction in phosphorylated Ca²⁺/Calmodulin protein kinase II, which has distinct effects on inactivation of cardiac Na⁺ channels. In a canine AP model, alterations of INa-L are sufficient to reproduce the effects on APD observed in DHF and CRT myocytes. CONCLUSIONS: CRT improves DHF-induced alterations of Na⁺ channel function, especially suppression of INa-L, thus, abbreviating the APD and reducing the frequency of early afterdepolarizations. Changes in the levels of phosphorylated Ca²⁺/Calmodulin protein kinase II suggest a molecular pathway for regulation of INa by biventricular pacing of the failing heart.
BACKGROUND: Slowed Na⁺ current (INa) decay and enhanced late INa (INa-L) prolong the action potential duration (APD) and contribute to early afterdepolarizations. Cardiac resynchronization therapy (CRT) shortens APD compared with dyssynchronous heart failure (DHF); however, the role of altered Na⁺ channel gating in CRT remains unexplored. METHODS AND RESULTS: Adult dogs underwent left-bundle branch ablation and right atrial pacing (200 beats/min) for 6 weeks (DHF) or 3 weeks followed by 3 weeks of biventricular pacing at the same rate (CRT). INa and INa-L were measured in left ventricular myocytes from nonfailing, DHF, and CRT dogs. DHF shifted voltage-dependence of INa availability by -3 mV compared with nonfailing, enhanced intermediate inactivation, and slowed recovery from inactivation. CRT reversed the DHF-induced voltage shift of availability, partially reversed enhanced intermediate inactivation but did not affect DHF-induced slowed recovery. DHF markedly increased INa-L compared with nonfailing. CRT dramatically reduced DHF-induced enhanced INa-L, abbreviated the APD, and suppressed early afterdepolarizations. CRT was associated with a global reduction in phosphorylated Ca²⁺/Calmodulin protein kinase II, which has distinct effects on inactivation of cardiac Na⁺ channels. In a canine AP model, alterations of INa-L are sufficient to reproduce the effects on APD observed in DHF and CRT myocytes. CONCLUSIONS: CRT improves DHF-induced alterations of Na⁺ channel function, especially suppression of INa-L, thus, abbreviating the APD and reducing the frequency of early afterdepolarizations. Changes in the levels of phosphorylated Ca²⁺/Calmodulin protein kinase II suggest a molecular pathway for regulation of INa by biventricular pacing of the failing heart.
Authors: Sanda Despa; Mohammed A Islam; Christopher R Weber; Steven M Pogwizd; Donald M Bers Journal: Circulation Date: 2002-05-28 Impact factor: 29.690
Authors: Stefan Wagner; Hanna M Ruff; Sarah L Weber; Sarah Bellmann; Thomas Sowa; Timo Schulte; Mark E Anderson; Eleonora Grandi; Donald M Bers; Johannes Backs; Luiz Belardinelli; Lars S Maier Journal: Circ Res Date: 2011-01-20 Impact factor: 17.367
Authors: Christophe Leclercq; Owen Faris; Richard Tunin; Jennifer Johnson; Ritsuchi Kato; Frank Evans; Julio Spinelli; Henry Halperin; Elliot McVeigh; David A Kass Journal: Circulation Date: 2002-10-01 Impact factor: 29.690
Authors: David D Spragg; Christophe Leclercq; Morteza Loghmani; Owen P Faris; Richard S Tunin; Deborah DiSilvestre; Elliot R McVeigh; Gordon F Tomaselli; David A Kass Journal: Circulation Date: 2003-08-18 Impact factor: 29.690
Authors: Charles Antzelevitch; Luiz Belardinelli; Andrew C Zygmunt; Alexander Burashnikov; José M Di Diego; Jeffrey M Fish; Jonathan M Cordeiro; George Thomas Journal: Circulation Date: 2004-08-09 Impact factor: 29.690
Authors: Stefan Wagner; Tim Seidler; Eckard Picht; Lars S Maier; Victor Kazanski; Nils Teucher; Wolfgang Schillinger; Burkert Pieske; Gerrit Isenberg; Gerd Hasenfuss; Harald Kögler Journal: Cardiovasc Res Date: 2003-11-01 Impact factor: 10.787
Authors: Kenneth Bilchick; Hema Kothari; Aditya Narayan; James Garmey; Abdullah Omar; Brian Capaldo; Coleen McNamara Journal: Cardiovasc Res Date: 2020-06-01 Impact factor: 10.787
Authors: Andrea Sorrentino; Sergio Signore; Khaled Qanud; Giulia Borghetti; Marianna Meo; Antonio Cannata; Yu Zhou; Ewa Wybieralska; Marco Luciani; Ramaswamy Kannappan; Eric Zhang; Alex Matsuda; Andrew Webster; Maria Cimini; Elizabeth Kertowidjojo; David A D'Alessandro; Oriyanhan Wunimenghe; Robert E Michler; Christopher Royer; Polina Goichberg; Annarosa Leri; Edward G Barrett; Piero Anversa; Thomas H Hintze; Marcello Rota Journal: Am J Physiol Heart Circ Physiol Date: 2016-01-22 Impact factor: 4.733
Authors: Sophie Burel; Fabien C Coyan; Maxime Lorenzini; Matthew R Meyer; Cheryl F Lichti; Joan H Brown; Gildas Loussouarn; Flavien Charpentier; Jeanne M Nerbonne; R Reid Townsend; Lars S Maier; Céline Marionneau Journal: J Biol Chem Date: 2017-09-07 Impact factor: 5.157